ALVO
Alvotech
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IS
$5.87
+9.93%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.03
- Revenue estimate
- $132.9M
Latest reported
- Last report date
- Aug 20, 2026
- EPS actual
- -$0.11
- EPS estimate
- -$0.05
- Revenue actual
- $106.0M
- Revenue estimate
- $102.9M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -1653.1%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $7.50
- PT range
- $7.00 – $8.00
- Analysts
- 3
3 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 20, 2026 | -$0.05 | -$0.11 | Miss -109.13% | $106.0M |
| May 7, 2026 | -$0.07 | -$0.09 | Miss -28.57% | $105.9M |
| Mar 19, 2026 | -$0.01 | -$0.37 | Miss -6334.78% | $173.2M |
| Nov 12, 2025 | $0.05 | -$0.02 | Miss -140.00% | $114.0M |
| Aug 13, 2025 | -$0.26 | $0.14 | Beat 153.85% | $173.2M |
| May 7, 2025 | -$0.17 | $0.35 | Beat 305.88% | $132.8M |
| Mar 26, 2025 | -$0.39 | -$0.24 | Beat 38.46% | $151.2M |
| Nov 13, 2024 | -$0.06 | $0.19 | Beat 401.59% | $489.7M |
| Aug 15, 2024 | -$0.28 | $0.28 | Beat 200.00% | $198.8M |
| May 21, 2024 | -$0.08 | -$0.89 | Miss -972.29% | $12.4M |
| Mar 20, 2024 | $0.15 | -$1.22 | Miss -913.33% | $53.4M |
| Nov 28, 2023 | -$0.29 | -$0.82 | Miss -182.76% | $17.8M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026